Robert Crotty Email

General Counsel . Inovio Pharmaceuticals

Plymouth Meeting, PA

Location

Current Roles

Employees:
229
Revenue:
$6.5M
About
Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery, development, and delivery of DNA vaccines with a focus on cancers and infectious diseases. The company’s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against new, unmatched strains of pathogens, such as influenza. Its electroporation DNA delivery technology uses controlled electrical pulses to enhance cellular DNA vaccine uptake. The company’s clinical programs include human papillomavirus/cervical cancer (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), and hepatitis C virus and human immunodeficiency virus vaccines. It is also advancing preclinical research and clinical development for a seasonal/pandemic influenza vaccine, as well as preclinical work for other products, including malaria and prostate cancer vaccines. The company was formerly known as Inovio Biomedical Corporation and changed its name to Inovio Pharmaceuticals, Inc. in May 2010. Inovio Pharmaceuticals, Inc. was founded in 1983 and is headquartered in Blue Bell, Pennsylvania.
Inovio Pharmaceuticals Address
660 West Germantown Pike
Plymouth Meeting, PA
United States
Inovio Pharmaceuticals Email

Past Companies

INOVIO Pharmaceuticals, Inc.General Counsel
Nabriva Therapeutics plcGeneral Counsel & Secretary
VernalisGeneral Counsel, Chief Compliance Officer & Secretary

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.